Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) EBT Margin (2019 - 2024)

Intelligent Bio Solutions has reported EBT Margin over the past 6 years, most recently at 362.44% for Q1 2024.

  • Quarterly results put EBT Margin at 362.44% for Q1 2024, up 102732.0% from a year ago — trailing twelve months through Mar 2024 was 363.35% (up 13670.0% YoY), and the annual figure for FY2023 was 1001.34%, down 46929.0%.
  • EBT Margin for Q1 2024 was 362.44% at Intelligent Bio Solutions, down from 264.42% in the prior quarter.
  • Over the last five years, EBT Margin for INBS hit a ceiling of 174.6% in Q2 2022 and a floor of 9164.97% in Q1 2021.
  • Median EBT Margin over the past 5 years was 641.14% (2020), compared with a mean of 1665.46%.
  • Biggest five-year swings in EBT Margin: skyrocketed 23150642bps in 2020 and later tumbled -191728bps in 2021.
  • Intelligent Bio Solutions' EBT Margin stood at 703.23% in 2020, then plummeted by -177bps to 1948.26% in 2021, then skyrocketed by 69bps to 597.03% in 2022, then surged by 56bps to 264.42% in 2023, then tumbled by -37bps to 362.44% in 2024.
  • The last three reported values for EBT Margin were 362.44% (Q1 2024), 264.42% (Q4 2023), and 322.03% (Q3 2023) per Business Quant data.